Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$956M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$924M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$769M |
| 4 |
Vanguard Morningstar Value ETF
VTV
|
+$410M |
| 5 |
Kenvue
KVUE
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$411M |
| 2 |
Johnson & Johnson
JNJ
|
+$234M |
| 3 |
Cisco
CSCO
|
+$181M |
| 4 |
iShares Gold Trust
IAU
|
+$143M |
| 5 |
LSI
Life Storage, Inc.
LSI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.03% |
| 2 | Healthcare | 12.31% |
| 3 | Financials | 11.79% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
TFS Financial
TFSL
$5.17B
| $4.84M | ﹤0.01% |
409,220
+32,496
| +9% | +$435K |
|
2277
Paysafe
PSFE
$402M
| $4.82M | ﹤0.01% |
402,092
-20,254
| -5% | -$246K |
|
2278
Artivion
AORT
$1.33B
| $4.82M | ﹤0.01% |
317,995
+2,659
| +0.8% | +$43.1K |
|
|
VERV
2279
DELISTED
Verve Therapeutics
VERV
| $4.81M | ﹤0.01% |
363,044
+27,605
| +8% | +$445K |
|
2280
Viridian Therapeutics
VRDN
$2.13B
| $4.8M | ﹤0.01% |
313,217
+197,430
| +171% | +$3.77M |
|
2281
Covenant Logistics
CVLG
$888M
| $4.8M | ﹤0.01% |
219,074
-7,892
| -3% | -$191K |
|
2282
iShares MSCI EAFE ETF
EFA
$78.4B
| $4.78M | ﹤0.01% |
69,418
+39,407
| +131% | +$2.82M |
|
2283
Corsair Gaming
CRSR
$1.15B
| $4.78M | ﹤0.01% |
329,257
+23,165
| +8% | +$373K |
|
2284
Stem
STEM
$50.3M
| $4.78M | ﹤0.01% |
56,390
+1,950
| +4% | +$223K |
|
|
EBIX
2285
DELISTED
Ebix Inc
EBIX
| $4.74M | ﹤0.01% |
479,517
+45,535
| +10% | +$885K |
|
|
IAS
2286
DELISTED
Integral Ad Science
IAS
| $4.74M | ﹤0.01% |
398,422
+65,160
| +20% | +$1.01M |
|
2287
CleanSpark
CLSK
$3.76B
| $4.72M | ﹤0.01% |
1,237,533
+905,993
| +273% | +$4.78M |
|
2288
Accel Entertainment
ACEL
$979M
| $4.71M | ﹤0.01% |
430,589
+27,218
| +7% | +$304K |
|
|
HAYN
2289
DELISTED
Haynes International, Inc.
HAYN
| $4.7M | ﹤0.01% |
101,046
+64,204
| +174% | +$3.13M |
|
2290
Arcturus Therapeutics
ARCT
$171M
| $4.7M | ﹤0.01% |
183,941
+5,435
| +3% | +$167K |
|
2291
Adaptive Biotechnologies
ADPT
$3.68B
| $4.68M | ﹤0.01% |
859,067
+21,177
| +3% | +$140K |
|
2292
Cardlytics
CDLX
$23.6M
| $4.67M | ﹤0.01% |
28,309
+3,223
| +13% | +$419K |
|
2293
Beyond Meat
BYND
$316M
| $4.65M | ﹤0.01% |
483,732
+30,998
| +7% | +$404K |
|
2294
GoPro
GPRO
$131M
| $4.65M | ﹤0.01% |
1,480,749
+231,018
| +18% | +$877K |
|
|
CDMO
2295
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $4.64M | ﹤0.01% |
491,006
+12,553
| +3% | +$151K |
|
2296
Shell
SHEL
$252B
| $4.63M | ﹤0.01% |
71,977
+28,165
| +64% | +$1.75M |
|
2297
Cytek Biosciences
CTKB
$557M
| $4.61M | ﹤0.01% |
835,693
+136,201
| +19% | +$1.09M |
|
2298
Comtech Telecommunications
CMTL
$49.7M
| $4.61M | ﹤0.01% |
527,106
+21,431
| +4% | +$200K |
|
|
PNT
2299
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $4.6M | ﹤0.01% |
689,179
+446,910
| +184% | +$3.71M |
|
2300
LSB Industries
LXU
$707M
| $4.59M | ﹤0.01% |
449,106
+36,505
| +9% | +$378K |
|
Similar funds
Charles Schwab's Q3 2023 Portfolio in Review
As of Q3 2023, Charles Schwab held 3,713 positions worth $349B, down 0.3% from $350B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $12.6B of net new capital in Q3 2023, opening 104 new positions and adding to 2,394 existing holdings. Its largest new stake was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $234M trimmed.
- Charles Schwab's largest Q3 2023 buy was Vanguard Morningstar Value ETF: 2,862,740 shares worth $395M.
- Charles Schwab added most to iShares Core US Aggregate Bond ETF in Q3 2023, an estimated $956M increase.
- Charles Schwab's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $234M.
- Charles Schwab fully exited iShares 0-5 Year TIPS Bond ETF in Q3 2023, selling an estimated $411M.
- Charles Schwab's ten largest holdings make up 18% of its $349B portfolio in Q3 2023.
- Charles Schwab opened 104 new positions and closed 137 in Q3 2023.
- Charles Schwab's portfolio value fell 0.3% quarter-over-quarter to $349B.
Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.